369 related articles for article (PubMed ID: 9039133)
1. Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide.
Li P; Chappell MC; Ferrario CM; Brosnihan KB
Hypertension; 1997 Jan; 29(1 Pt 2):394-400. PubMed ID: 9039133
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide.
Brosnihan KB; Li P; Ferrario CM
Hypertension; 1996 Mar; 27(3 Pt 2):523-8. PubMed ID: 8613197
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-(1-7): a novel vasodilator of the coronary circulation.
Brosnihan KB; Li P; Tallant EA; Ferrario CM
Biol Res; 1998; 31(3):227-34. PubMed ID: 9830510
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of angiotensin-(1-7) on bradykinin arteriolar dilation in vivo.
Oliveira MA; Fortes ZB; Santos RA; Kosla MC; De Carvalho MH
Peptides; 1999; 20(10):1195-201. PubMed ID: 10573291
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin 1-7 induces bradykinin-mediated relaxation in porcine coronary artery.
Gorelik G; Carbini LA; Scicli AG
J Pharmacol Exp Ther; 1998 Jul; 286(1):403-10. PubMed ID: 9655885
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo.
Fernandes L; Fortes ZB; Nigro D; Tostes RC; Santos RA; Catelli De Carvalho MH
Hypertension; 2001 Feb; 37(2 Pt 2):703-9. PubMed ID: 11230360
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.
Greco AJ; Master RG; Fokin A; Baber SR; Kadowitz PJ
Can J Physiol Pharmacol; 2006 Nov; 84(11):1163-75. PubMed ID: 17218981
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of neutral endopeptidase by thiorphan does not modify coronary vascular responses to angiotensin I, angiotensin II and bradykinin in the isolated guinea pig heart.
Kozlovski VI; Lomnicka M; Jakubowski A; Chlopicki S
Pharmacol Rep; 2007; 59(4):421-7. PubMed ID: 17901571
[TBL] [Abstract][Full Text] [Related]
9. Gynura procumbens causes vasodilation by inhibiting angiotensin II and enhancing bradykinin actions.
Poh TF; Ng HK; Hoe SZ; Lam SK
J Cardiovasc Pharmacol; 2013 May; 61(5):378-84. PubMed ID: 23328388
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the vasodilatory effects of bradykinin in isolated dog renal arteries and in buffer-perfused dog kidneys.
Malomvölgyi B; Hadházy P; Tekes K; Koltai MZ; Pogátsa G
Acta Physiol Hung; 1996; 84(1):9-18. PubMed ID: 8993670
[TBL] [Abstract][Full Text] [Related]
11. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
[TBL] [Abstract][Full Text] [Related]
12. Bradykinin-induced vascular responses in dog isolated lingual artery.
Tsukada M; Chiba S
Clin Exp Pharmacol Physiol; 1999; 26(5-6):456-60. PubMed ID: 10386238
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade.
Tom B; de Vries R; Saxena PR; Danser AH
Hypertension; 2001 Jul; 38(1):95-9. PubMed ID: 11463767
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors.
Mombouli JV; Illiano S; Nagao T; Scott-Burden T; Vanhoutte PM
Circ Res; 1992 Jul; 71(1):137-44. PubMed ID: 1318793
[TBL] [Abstract][Full Text] [Related]
15. Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism.
Zanzinger J; Zheng X; Bassenge E
Cardiovasc Res; 1994 Feb; 28(2):209-14. PubMed ID: 8143302
[TBL] [Abstract][Full Text] [Related]
16. The role of bradykinin, AT2 and angiotensin 1-7 receptors in the EDRF-dependent vasodilator effect of angiotensin II on the isolated mesenteric vascular bed of the rat.
Soares de Moura R; Resende AC; Emiliano AF; Tano T; Mendes-Ribeiro AC; Correia ML; de Carvalho LC
Br J Pharmacol; 2004 Mar; 141(5):860-6. PubMed ID: 14757704
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type 1 receptor blockade restores angiotensin-(1-7)-induced coronary vasodilation in hypertrophic rat hearts.
Souza ÁP; Sobrinho DB; Almeida JF; Alves GM; Macedo LM; Porto JE; Vêncio EF; Colugnati DB; Santos RA; Ferreira AJ; Mendes EP; Castro CH
Clin Sci (Lond); 2013 Nov; 125(9):449-59. PubMed ID: 23718715
[TBL] [Abstract][Full Text] [Related]
18. Coronary vasodilation induced by angiotensin-converting enzyme inhibition in vivo: differential contribution of nitric oxide and bradykinin in conductance and resistance arteries.
Sudhir K; Chou TM; Hutchison SJ; Chatterjee K
Circulation; 1996 May; 93(9):1734-9. PubMed ID: 8653880
[TBL] [Abstract][Full Text] [Related]
19. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation.
Seyedi N; Xu X; Nasjletti A; Hintze TH
Hypertension; 1995 Jul; 26(1):164-70. PubMed ID: 7607720
[TBL] [Abstract][Full Text] [Related]
20. Improvement by phosphoramidon of damaged endothelial function in porcine coronary artery.
Krassói I; Pataricza J; Torday LL; Kun A; Papp JG
Ann Thorac Surg; 2000 Sep; 70(3):878-82. PubMed ID: 11016327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
